Prevalence
Causes
Clinical
features
Investigations
Therapy
Prevention
Prognosis
|  |  | | Therapy |
DC cardioversion
Consider using transoesophageal echocardiography to determine when to
perform the cardioversion a 
- No thrombus detected - DC cardioversion, and warfarin for 4
weeks.
- Thrombus detected - warfarin for 3 weeks, then repeated
echocardiogram.
- If no thrombus then, DC cardioversion and warfarin for 4
weeks.
- If thrombus, no DC cardioversion and warfarin for 4 weeks.
Why?
- Using transoesophageal echocardiography to determine when cardioversion should occur
leads to fewer bleeds on warfarin but has no clear effect on embolic
events or the duration of any sinus rhythm achieved. d

- Using it to predict which patients
require anticoagulation b
has no clear effect on subsequent embolic events. d
Ibutilide is effective at cardioversion,
but cause ventricular tachycardia
| Patient |
Treatment |
Comparison |
Outcome |
CER |
RRR
(95% CI) |
NNT
(95% CI) |
AF for > 2 days or atrial flutter with a history of AF a
 |
DC cardioversion guided by transoesophageal echocardiography |
standard DC cardioversion |
haemorrhage
at 8 weeks |
5.5% |
47%
(7% to 70%) |
39
(21 to 320) |
|